| Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study GJAM Boon, YM Ende-Verhaar, R Bavalia, LH El Bouazzaoui, M Delcroix, ... Thorax 76 (10), 1002-1009, 2021 | 57 | 2021 |
| Noninvasive tests do not accurately differentiate nonalcoholic steatohepatitis from simple steatosis: a systematic review and meta-analysis P Verhaegh, R Bavalia, B Winkens, A Masclee, D Jonkers, G Koek Clinical Gastroenterology and Hepatology 16 (6), 837-861, 2018 | 54 | 2018 |
| Emergencies on direct oral anticoagulants: management, outcomes, and laboratory effects of prothrombin complex concentrate R Bavalia, R Abdoellakhan, HJM Brinkman, MPA Brekelmans, ... Research and practice in thrombosis and haemostasis 4 (4), 569-581, 2020 | 29 | 2020 |
| Time scales of human monkeypox transmission in the Netherlands F Miura, JA Backer, G van Rijckevorsel, R Bavalia, S Raven, M Petrignani, ... medRxiv, 2022.12. 03.22283056, 2022 | 17* | 2022 |
| Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of … M Candeloro, N van Es, N Cantor, S Schulman, M Carrier, W Ageno, ... Journal of Thrombosis and Haemostasis, 0 | 14 | |
| Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study SV Hendriks, R Bavalia, T van Bemmel, IM Bistervels, M Eijsvogel, ... Thrombosis Research 193, 60-65, 2020 | 11 | 2020 |
| Treatment of venous thromboembolism in special populations with direct oral anticoagulants R Bavalia, S Middeldorp, G Weisser, C Kearon, E Akl, J Ornelas, ... Thrombosis and haemostasis 120 (06), 899-911, 2020 | 11 | 2020 |
| Direct oral anticoagulant blood level monitoring in daily practice R Bavalia, JE Veenhuizen, RCC Hengeveld, D Braeken, AJW Gulpen, ... Thrombosis Update 3, 100049, 2021 | 10 | 2021 |
| Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study HM Hamer, AK Stroobants, R Bavalia, GAE Ponjee, FA Klok, ... Thrombosis Research 201, 18-22, 2021 | 10 | 2021 |
| Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS Study R Bavalia, MAM Stals, FI Mulder, IM Bistervels, M Coppens, LM Faber, ... Emergency Medicine Journal 40 (1), 61-66, 2023 | 9 | 2023 |
| Epidemiologic and genomic analysis of SARS-CoV-2 Delta variant Superspreading event in nightclub, the Netherlands, June 2021 J Koopsen, CE van Ewijk, R Bavalia, A Cornelissen, SM Bruisten, ... Emerging infectious diseases 28 (5), 1012, 2022 | 9 | 2022 |
| Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism IM Bistervels, R Bavalia, M Gebel, AWA Lensing, S Middeldorp, MH Prins, ... Journal of Thrombosis and Haemostasis 20 (6), 1376-1384, 2022 | 8 | 2022 |
| Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin R Bavalia, IM Bistervels, WG Boersma, I Quere, D Brisot, N Falvo, ... Research and Practice in Thrombosis and Haemostasis 5 (5), e12566, 2021 | 5 | 2021 |
| Circulation, viral diversity and genomic rearrangement in mpox virus in the Netherlands during the 2022 outbreak and beyond L Schuele, M Boter, DF Nieuwenhuijse, H Götz, E Fanoy, H de Vries, ... Journal of Medical Virology 96 (1), e29397, 2024 | 3 | 2024 |
| Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May–July 2022 CE van Ewijk, C Smit, R Bavalia, K Ainslie, A Vollaard, G van Rijckevorsel, ... Vaccine 41 (47), 6952-6959, 2023 | 3 | 2023 |
| Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin IM Bistervels, R Bavalia, J Beyer‐Westendorf, AJ ten Cate‐Hoek, ... Research and Practice in Thrombosis and Haemostasis 6 (5), e12748, 2022 | 3 | 2022 |
| Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation SFB van der Horst, TAC de Vries, G Chu, R Bavalia, H Xiong, ... TH Open 7 (03), e270-e279, 2023 | 2 | 2023 |
| Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism D Luijten, FMM Meijer, GJAM Boon, YM Ende-Verhaar, R Bavalia, ... Journal of Electrocardiology 74, 94-100, 2022 | 1 | 2022 |
| Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonists R Bavalia, R Abdoellakhan, LF Beenen, MPA Brekelmans, RH Olie, ... Thrombosis research 196, 404-409, 2020 | 1 | 2020 |
| Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors M Coppens, L Xu, R Bavalia, S Middeldorp, P Verhamme, JW Eikelboom, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 1 | 2019 |
